Cargando…
Systematic Review of miRNA as Biomarkers in Alzheimer’s Disease
Currently there are 850,000 people with Alzheimer’s disease in the UK, with an estimated rise to 1.1 million by 2025. Alzheimer’s disease is characterised by the accumulation of amyloid-beta plaques and hyperphosphorylated tau in the brain causing a progressive decline in cognitive impairment. Small...
Autores principales: | Swarbrick, S., Wragg, N., Ghosh, S., Stolzing, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682547/ https://www.ncbi.nlm.nih.gov/pubmed/30734227 http://dx.doi.org/10.1007/s12035-019-1500-y |
Ejemplares similares
-
Circulating miRNA Biomarkers for Alzheimer's Disease
por: Kumar, Pavan, et al.
Publicado: (2013) -
miRNA biomarkers in renal disease
por: Franczyk, Beata, et al.
Publicado: (2021) -
Cryopreservation of Mesenchymal Stem Cells Using Medical Grade Ice Nucleation Inducer
por: Wragg, Nicholas M., et al.
Publicado: (2020) -
Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
por: Manna, Ida, et al.
Publicado: (2020) -
MicroRNA (miRNA) Complexity in Alzheimer’s Disease (AD)
por: Lukiw, Walter J.
Publicado: (2023)